BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35277188)

  • 1. A novel inflammation-related prognostic biomarker for predicting the disease-free survival of patients with colorectal cancer.
    Cai X; Chen F; Liang L; Jiang W; Liu X; Wang D; Wu Y; Chen J; Guan G; Peng XE
    World J Surg Oncol; 2022 Mar; 20(1):79. PubMed ID: 35277188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
    Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
    Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
    Liu SX; Zhang L; Shi YK; Han XH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative inflammation and nutrition-based comprehensive biomarker for predicting prognosis in resectable colorectal cancer.
    Cai H; Li J; Chen Y; Zhang Q; Liu Y; Jia H
    Front Oncol; 2023; 13():1279487. PubMed ID: 38074640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.
    Zhuang Z; Li Y; Hong Y; Chen L; Qian J; Lin J; Chen Q; Qiu Y; Lin L; Shi B; Pan L; Zheng X; Wang J; Liu F; He B; Chen F
    Oral Dis; 2022 Apr; 28(3):631-638. PubMed ID: 33426698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.
    Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ
    World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
    Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
    Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
    Zheng Y; Wu C; Yan H; Chen S
    Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
    You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
    Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.
    Zhou S; He Q; Sheng N; Gong J; Ren J; Wang Z
    World J Surg Oncol; 2022 Jan; 20(1):18. PubMed ID: 35033097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
    Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
    World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Inflammatory Biomarkers in Gastric Cancer Patients and the Construction of a Predictive Model.
    Ma M; Wang J; Hu Y; Weng M; Liu X; Wang Y
    Dig Surg; 2019; 36(5):433-442. PubMed ID: 30300879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a Nomogram Based on the Integration of Inflammation Markers with Tumor Staging in Prognosis Prediction of Stage III Colorectal Cancer.
    Wang L; Xiao J; Li MZ; Teng WH; Jia J; Lin L; Liu S; Ye XM; Zang WD; Chen Y
    Cancer Manag Res; 2020; 12():7077-7085. PubMed ID: 32821170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients.
    Qi J; Zhang J; Ge X; Wang X; Xu L; Liu N; Zhao L; Wang P
    Front Oncol; 2021; 11():713014. PubMed ID: 34692490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic scoring system based on eosinophil- and basophil-related markers for predicting the prognosis of patients with stage II and stage III colorectal cancer: a retrospective cohort study.
    Gao L; Yuan C; Fu J; Tian T; Huang H; Zhang L; Li D; Liu Y; Meng S; Liu Y; Zhang Y; Xu J; Jia C; Zhang D; Zheng T; Fu Q; Tan S; Lan L; Yang C; Zhao Y; Liu Y
    Front Oncol; 2023; 13():1182944. PubMed ID: 37519795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.